Vertex Venture Holdings gets funds to go global

05 October 2015

Armed with a war chest of US$600 million (S$857 million), Singapore’s largest and oldest venture capital firm is going global. The infusion of cash will allow Vertex Venture Holdings to invest in start-ups in the hot seats of innovation and technological disruption – United States, Israel and China – after having been mainly focused on […]

Continue Reading

Visterra Closes $30 Million Series B Financing – Co-led by New Investors, Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek

02 October 2014

Cambridge, MA – October 2, 2014 Visterra, Inc., a biotechnology company that uses its proprietary technology platform to identify unique disease targets and design novel therapeutics, today announced that it has completed a $30 million Series B financing round. The proceeds will be used to advance the development of multiple product candidates from the company’s […]

Continue Reading